Liver Injury and Its Impact on Prognosis in Patients with HBV-Related Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors
Lists
Only you see this
Abstract
Liver injury adverse events are common in HBV-related HCC patients treated with TACE-TKIs-ICIs. Patients who developed liver injury had a poor prognosis. For HBV-related HCC patients, effective prophylactic antiviral therapy and regular liver function testing are required before and during this triple therapy.
BibTeX
@article{shen2024liver,
author = {Jiaming Shen and Xia Wang and Guangde Yang and Li Li and Juan Fu and Wei Xu and Qingqiao Zhang and Xiucheng Pan},
title = {{Liver Injury and Its Impact on Prognosis in Patients with HBV-Related Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors}},
journal = {Journal of Hepatocellular Carcinoma},
year = {2024},
doi = {10.2147/jhc.s431191},
}Loading related content...